{"nct_id":"NCT02345252","title":"Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF)","status":"COMPLETED","status_verified_date":"2019-12","start_date":"2015-01-26","start_date_type":"ACTUAL","primary_completion_date":"2016-06-22","primary_completion_date_type":"ACTUAL","completion_date":"2019-01-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}